Prot # 101JC402: JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri: STRATIFY-2

Project: Research project

Project Details

StatusFinished
Effective start/end date7/28/10 → 7/28/16

Funding

  • United BioSource LLC (Prot # 101JC402 // Prot # 101JC402)
  • Biogen Inc. (Prot # 101JC402 // Prot # 101JC402)